Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (261-270 of 280) with videos related to

Pageof 28
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1)Michèle Beau-Faller, Armelle Degeorges, Estelle Rolland, et al.
European Journal of Human Genetics : EJHG|June 21, 2012
Toward a roadmap in global biobanking for healthJennifer R Harris, Paul Burton, Bartha Maria Knoppers, et al.
Journal of Hematology & Oncology|August 16, 2022
Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German RegistryJudith Penkert, Farina J Strüwe, Christina M Dutzmann, et al.
Cancer Genetics|September 4, 2012
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortiumPhuong L Mai, David Malkin, Judy E Garber, et al.
Cancer Research|March 4, 2017
Recommended Guidelines for Validation, Quality Control, and Reporting of <i>TP53</i> Variants in Clinical PracticeBernard Leroy, Mandy L Ballinger, Fanny Baran-Marszak, et al.
Allergy|April 12, 2020
A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescentsNathanaël Lemonnier, Erik Melén, Yale Jiang, et al.
Cancer Research|July 5, 2006
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective studyEmmanuelle Gormally, Paolo Vineis, Giuseppe Matullo, et al.
International Journal of Cancer|July 15, 2004
Amount of DNA in plasma and cancer risk: a prospective studyEmmanuelle Gormally, Pierre Hainaut, Elodie Caboux, et al.
International Journal of Cancer|February 8, 2006
Air pollution and risk of lung cancer in a prospective study in EuropePaolo Vineis, Gerard Hoek, Michal Krzyzanowski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 25, 2010
Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC)Silvia Franceschi, Mauro Lise, Christian Trépo, et al.
Pageof 28

Showing results (261-270 of 280) with videos related to

Sort By:
Pageof 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1)Michèle Beau-Faller, Armelle Degeorges, Estelle Rolland, et al.
European Journal of Human Genetics : EJHG|June 21, 2012
Toward a roadmap in global biobanking for healthJennifer R Harris, Paul Burton, Bartha Maria Knoppers, et al.
Journal of Hematology & Oncology|August 16, 2022
Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German RegistryJudith Penkert, Farina J Strüwe, Christina M Dutzmann, et al.
Cancer Genetics|September 4, 2012
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortiumPhuong L Mai, David Malkin, Judy E Garber, et al.
Cancer Research|March 4, 2017
Recommended Guidelines for Validation, Quality Control, and Reporting of <i>TP53</i> Variants in Clinical PracticeBernard Leroy, Mandy L Ballinger, Fanny Baran-Marszak, et al.
Allergy|April 12, 2020
A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescentsNathanaël Lemonnier, Erik Melén, Yale Jiang, et al.
Cancer Research|July 5, 2006
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective studyEmmanuelle Gormally, Paolo Vineis, Giuseppe Matullo, et al.
International Journal of Cancer|July 15, 2004
Amount of DNA in plasma and cancer risk: a prospective studyEmmanuelle Gormally, Pierre Hainaut, Elodie Caboux, et al.
International Journal of Cancer|February 8, 2006
Air pollution and risk of lung cancer in a prospective study in EuropePaolo Vineis, Gerard Hoek, Michal Krzyzanowski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 25, 2010
Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC)Silvia Franceschi, Mauro Lise, Christian Trépo, et al.
Pageof 28